Arkolith/Insider Trading/KURA/Form 4

Hasnain Faheem

DirectorKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$110K
Net Open-Market Flow
-$110K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Option exercise(M)10K$3.12$31K34K
Dec 9, 2025Sell(S)10K$10.98$110K24K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-314154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML